Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Receivables - Net (2015 - 2026)

Mesoblast (MESO) posted Receivables - Net of $43.3 million for Q4 2025, up 191.27% sequentially from $14.9 million in Q2 2025, and up 1345.26% YoY from $3.0 million in Q4 2024.

Analysis

Mesoblast (MESO) Receivables - Net (2015 - 2026) Analysis & Trends

Mesoblast has reported Receivables - Net for 10 years, with the latest figure at $43.3 million in Q4 2025.

  • Quarterly Receivables - Net rose 1345.26% year-over-year to $43.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $43.3 million (up 1345.26% YoY) and the FY2025 annual result came in at $14.9 million, down 29.05% from the prior year.
  • Receivables - Net climbed to $43.3 million in Q4 2025 per MESO's latest filing, from $14.9 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $43.3 million in Q4 2025 and troughed at $2.9 million in Q1 2021.
  • A 5-year average of $9.3 million and a median of $5.6 million in 2021 frame the typical range for Receivables - Net.
  • The sharpest annual moves came in 2022 and 2025: Receivables - Net slumped 31.35% in 2022, then surged 1345.26% in 2025.
  • Over 5 years, Receivables - Net stood at $6.0 million in 2021, then declined by 15.43% to $5.1 million in 2022, then slipped by 21.84% to $4.0 million in 2023, then retreated by 25.06% to $3.0 million in 2024, then soared by 1345.26% to $43.3 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods registered $43.3 million, $14.9 million, and $3.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mesoblast 2.24 Bn 2.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.66 Mn
Dec 31, 2025 43.30 Mn
Jun 30, 2025 14.87 Mn
Dec 31, 2024 3.00 Mn
Jun 30, 2024 20.95 Mn
Dec 31, 2023 4.00 Mn
Jun 30, 2023 7.00 Mn
Mar 31, 2023 8.39 Mn
Dec 31, 2022 5.12 Mn
Sep 30, 2022 3.86 Mn
Jun 30, 2022 4.40 Mn
Mar 31, 2022 5.63 Mn
Dec 31, 2021 6.05 Mn
Sep 30, 2021 5.63 Mn
Jun 30, 2021 4.84 Mn
Mar 31, 2021 2.95 Mn
Dec 31, 2020 3.34 Mn
Sep 30, 2020 2.45 Mn
Jun 30, 2020 1.57 Mn
Mar 31, 2020 3.00 Mn